Sagging stock prices in the second quarter of 2010 attracted the interest of the Bill and Melinda Gates Foundation and the foundation added the Goldman Sachs Group and Monsanto to its portfolio, according to the Dow Jones Newswires. The foundation recently bought about 500,000 shares of the giant biotech company, according to another financial website.
According to civil society organisations, the addition of Monsanto into the Gates Foundation’s portfolio also brings concern about Monsanto’s patenting practices and monopoly over seeds. Civil society is worried that Gates’ interest in Monsanto will worsen the conditions of small farmers in developing countries, and might represent a conflict of interest, according to the Community Alliance for Global Justice.
[…] to improve healthcare around the world, but the latest news is that the Foundation has decided to invest in Monsanto, a company famous for widely abusing intellectual property laws to make people a lot less healthy, […]
[…] Gates Foundation’s Monsanto Investment Stirs Civil Society: Intellectual Property Watch Blog (August 30th, 2010) […]
[…] This is unfortunate. The Bill & Melinda Gates Foundation has certainly been hard at work trying to improve healthcare around the world, but the latest news is that the Foundation has decided to invest in Monsanto, […]
[…] and US biotech companies are strong. Within nine months of his arriving at Gates, the foundation had invested $23m in Monsanto, but although it may partner biotech companies and governments such as the UK to develop GM crops, […]
[…] and US biotech companies are strong. Within nine months of his arriving at Gates, the foundation had invested $23m in Monsanto, but although it may partner biotech companies and governments such as the UK to develop GM crops, […]
[…] and US biotech companies are strong. Within nine months of his arriving at Gates, the foundationhad invested $23m in Monsanto, but although it may partner biotech companies and governments such as the UK to develop GM crops, […]